Skip to content
value.today

Icon Bioscience, Inc.

Total raised
$15 M
1 round on record
Latest round
$15 M
Aug 2013
First round on record
Aug 2013
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Icon Bioscience, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2013$15 MNo. 1$10 to $50 million

Icon Bioscience, Inc.: Raise no. 1, Aug 2013

Investors in this round

8 investors had bought by the notice of Aug 28, 2013: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $20 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
$448,264
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Vernon S. Wong · Executive Officer, Director
  • William S. White · Executive Officer, Director
  • Joyce S. Erony · Director
  • Song S. Tjoa · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Liberty Tree Advisors, LLC (CRD 143679) · Acton, MassachusettsSold in CA, CT, MA, MD, NJ, NY

Remarks in the notice

  • On fees: “Assumes offering fully subscribed--fee paid to date is $269,998.17. Warrants for up to 3,853 Common shares to be issued on full subscription--warrants for 2,461 shares issued to date.”

Signed by William S. White, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 28, 2013. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Icon Bioscience, Inc. had revenue of up to $1 million when it filed its newest notice of a funding round (Aug 2013).

    SEC Form D (revenue range) · Aug 2013

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Aug 2013

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Icon Bioscience, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 8 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Icon Bioscience, Inc.
NameRoleNamed in
Vernon S. WongExecutive officerAug 2013
William S. WhiteExecutive officerAug 2013
Joyce S. EronyDirectorAug 2013
Song S. TjoaDirectorAug 2013
Vernon S. WongDirectorAug 2013
William S. WhiteDirectorAug 2013